A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies
- 1 March 1991
- journal article
- review article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (3) , 758-769
- https://doi.org/10.1016/s0735-1097(10)80196-2
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Enhancement of Wound Healing by Topical Treatment with Epidermal Growth FactorNew England Journal of Medicine, 1989
- Angioscopic observation of the coronary luminal changes induced by percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1989
- Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplastyThe American Journal of Cardiology, 1989
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary AngioplastyNew England Journal of Medicine, 1988
- Retinoid effects on fibroblast proliferation and collagen synthesis in vitro and on fibrotic disease in vivoJournal of the American Academy of Dermatology, 1986
- Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood instituteThe American Journal of Cardiology, 1984
- Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study.Circulation, 1984
- The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis.Circulation, 1983
- Morphology after Transluminal Angioplasty in Human BeingsNew England Journal of Medicine, 1981